Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home Blood Pressure Intervention in the Community Trial
NCT05858944Recruiting
- Sponsor
- Shanghai Institute of Hypertension
- Start
- May 2023
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by Shanghai Institute of Hypertension. Primary endpoint: Composite of adverse cardiovascular events at 48 months. Started May 2023; status: recruiting.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05858944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05858944.